ADVERTISEMENT |
ADVERTISEMENT |
FDA approves generic testosterone replacement gel
Watson Pharmaceuticals has received FDA approval on its abbreviated new drug application for a generic version of testosterone gel 1% CIII. The drug is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.  designed to meet the evolving needs of physicians, nurses and other allied healthcare professionals. |
Keep visiting UrologyTimes.com for fresh content, news, opinions, editor's blogs and more.  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
![[Get Copyright Permissions]](http://license.icopyright.net/images/icopy-w.gif){kind=small}
Urology Times archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.